Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Adherence to antiretroviral therapy in HIV-positive adolescents in Uganda assessed by multiple methods: a prospective cohort study.

Wiens MO, MacLeod S, Musiime V, Ssenyonga M, Kizza R, Bakeera-Kitaka S, Odoi-Adome R, Ssali F.

Paediatr Drugs. 2012 Oct 1;14(5):331-5. doi: 10.2165/11599280-000000000-00000.

PMID:
22765225
2.

Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda.

Oyugi JH, Byakika-Tusiime J, Ragland K, Laeyendecker O, Mugerwa R, Kityo C, Mugyenyi P, Quinn TC, Bangsberg DR.

AIDS. 2007 May 11;21(8):965-71.

PMID:
17457090
3.

Assessment of HIV antiretroviral therapy adherence by measuring drug concentrations in hair among children in rural Uganda.

Olds PK, Kiwanuka JP, Nansera D, Huang Y, Bacchetti P, Jin C, Gandhi M, Haberer JE.

AIDS Care. 2015;27(3):327-32. doi: 10.1080/09540121.2014.983452. Epub 2014 Dec 6.

4.

Factors associated with long-term antiretroviral therapy attrition among adolescents in rural Uganda: a retrospective study.

Okoboi S, Ssali L, Yansaneh AI, Bakanda C, Birungi J, Nantume S, Okullu JL, Sharp AR, Moore DM, Kalibala S.

J Int AIDS Soc. 2016 Jul 20;19(5 Suppl 4):20841. doi: 10.7448/IAS.19.5.20841. eCollection 2016.

5.

Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting.

Oyugi JH, Byakika-Tusiime J, Charlebois ED, Kityo C, Mugerwa R, Mugyenyi P, Bangsberg DR.

J Acquir Immune Defic Syndr. 2004 Aug 15;36(5):1100-2.

PMID:
15247564
6.

HIV-Infected Ugandan Women on Antiretroviral Therapy Maintain HIV-1 RNA Suppression Across Periconception, Pregnancy, and Postpartum Periods.

Matthews LT, Ribaudo HB, Kaida A, Bennett K, Musinguzi N, Siedner MJ, Kabakyenga J, Hunt PW, Martin JN, Boum Y, Haberer JE, Bangsberg DR.

J Acquir Immune Defic Syndr. 2016 Apr 1;71(4):399-406. doi: 10.1097/QAI.0000000000000874.

7.

Pharmacy refill adherence outperforms self-reported methods in predicting HIV therapy outcome in resource-limited settings.

Sangeda RZ, Mosha F, Prosperi M, Aboud S, Vercauteren J, Camacho RJ, Lyamuya EF, Van Wijngaerden E, Vandamme AM.

BMC Public Health. 2014 Oct 4;14:1035. doi: 10.1186/1471-2458-14-1035.

8.

Hazardous alcohol consumption is not associated with CD4+ T-cell count decline among PLHIV in Kampala Uganda: A prospective cohort study.

Wandera B, Tumwesigye NM, Nankabirwa JI, Kambugu AD, Mafigiri DK, Kapiga S, Sethi AK.

PLoS One. 2017 Jun 30;12(6):e0180015. doi: 10.1371/journal.pone.0180015. eCollection 2017.

9.

Good adherence to HAART and improved survival in a community HIV/AIDS treatment and care programme: the experience of The AIDS Support Organization (TASO), Kampala, Uganda.

Abaasa AM, Todd J, Ekoru K, Kalyango JN, Levin J, Odeke E, Karamagi CA.

BMC Health Serv Res. 2008 Nov 20;8:241. doi: 10.1186/1472-6963-8-241.

10.

Interventions to improve adherence to antiretroviral therapy in children with HIV infection.

Bain-Brickley D, Butler LM, Kennedy GE, Rutherford GW.

Cochrane Database Syst Rev. 2011 Dec 7;(12):CD009513. doi: 10.1002/14651858.CD009513. Review.

PMID:
22161452
11.

Adherence to tablet and liquid formulations of antiretroviral medication for paediatric HIV treatment at an urban clinic in Uganda.

Bagenda A, Barlow-Mosha L, Bagenda D, Sakwa R, Fowler MG, Musoke PM.

Ann Trop Paediatr. 2011;31(3):235-45. doi: 10.1179/1465328111Y.0000000025.

PMID:
21781419
12.

Virologic, immunologic and clinical response of infants to antiretroviral therapy in Kampala, Uganda.

Tukei VJ, Murungi M, Asiimwe AR, Migisha D, Maganda A, Bakeera-Kitaka S, Kalyesubula I, Musoke P, Kekitiinwa A.

BMC Pediatr. 2013 Mar 27;13:42. doi: 10.1186/1471-2431-13-42.

13.

Barriers to antiretroviral adherence in HIV-positive patients receiving free medication in Kayunga, Uganda.

Senkomago V, Guwatudde D, Breda M, Khoshnood K.

AIDS Care. 2011 Oct;23(10):1246-53. doi: 10.1080/09540121.2011.564112. Epub 2011 Jun 21.

PMID:
21939403
14.

Long-term experience providing antiretroviral drugs in a fee-for-service HIV clinic in Uganda: evidence of extended virologic and CD4+ cell count responses.

Kabugo C, Bahendeka S, Mwebaze R, Malamba S, Katuntu D, Downing R, Mermin J, Weidle PJ.

J Acquir Immune Defic Syndr. 2005 Apr 15;38(5):578-83.

PMID:
15793369
15.
16.

Improving adherence and clinical outcomes through an HIV pharmacist's interventions.

Ma A, Chen DM, Chau FM, Saberi P.

AIDS Care. 2010 Oct;22(10):1189-94. doi: 10.1080/09540121003668102.

PMID:
20640958
17.

Rethinking the "pre" in pre-therapy counseling: no benefit of additional visits prior to therapy on adherence or viremia in Ugandans initiating ARVs.

Siedner MJ, Lankowski A, Haberer JE, Kembabazi A, Emenyonu N, Tsai AC, Muzoora C, Geng E, Martin JN, Bangsberg DR.

PLoS One. 2012;7(6):e39894. doi: 10.1371/journal.pone.0039894. Epub 2012 Jun 26.

18.

Longitudinal assessment of associations between food insecurity, antiretroviral adherence and HIV treatment outcomes in rural Uganda.

Weiser SD, Palar K, Frongillo EA, Tsai AC, Kumbakumba E, Depee S, Hunt PW, Ragland K, Martin J, Bangsberg DR.

AIDS. 2014 Jan 2;28(1):115-20. doi: 10.1097/01.aids.0000433238.93986.35.

19.

Improving clinic attendance and adherence to antiretroviral therapy through a treatment supporter intervention in Uganda: a randomized controlled trial.

Kunutsor S, Walley J, Katabira E, Muchuro S, Balidawa H, Namagala E, Ikoona E.

AIDS Behav. 2011 Nov;15(8):1795-802. doi: 10.1007/s10461-011-9927-9.

PMID:
21424272
20.

Improving adherence to antiretroviral treatment in Uganda with a low-resource facility-based intervention.

Obua C, Kayiwa J, Waako P, Tomson G, Balidawa H, Chalker J, Ross-Degnan D, Wahlstrom R.

Glob Health Action. 2014 Jun 4;7:24198. doi: 10.3402/gha.v7.24198. eCollection 2014.

Supplemental Content

Support Center